Drug-induced Asthma

[1]  K. Chung,et al.  Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough , 1996, Nature Medicine.

[2]  P. Leff.  Inverse agonism: theory and practice. , 1995, TIPS - Trends in Pharmacological Sciences.

[3]  T. Kenakin,et al.  Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor , 1995, Nature.

[4]  R. Wood.  Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. , 1995, British journal of clinical pharmacology.

[5]  M. Hargreaves,et al.  Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough , 1995, The Lancet.

[6]  G. Verleden,et al.  Beta 2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. , 1993, Journal of applied physiology.

[7]  J. Fowles,et al.  Detection of beta-blocker use in people with asthma. , 1992, Annals of allergy.

[8]  K. Stumpe,et al.  Airway responsiveness and cough induced by angiotensin converting enzyme inhibition. , 1992, Journal of human hypertension.

[9]  P. Barnes.  Modulation of neurotransmission in airways. , 1992, Physiological reviews.

[10]  W. Busse,et al.  Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. , 1992, Chest.

[11]  Y. Ito,et al.  Effects of procaterol, a beta-2-adrenoceptor stimulant, on neuroeffector transmission in human bronchial tissue. , 1991, Respiration; international review of thoracic diseases.

[12]  N. Choudry,et al.  The effect of sulindac on the abnormal cough reflex associated with dry cough. , 1990, The Journal of pharmacology and experimental therapeutics.

[13]  K. Chung,et al.  Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. , 1990, Thorax.

[14]  Y. Kamikawa,et al.  Inhibitory effects of catecholamines on cholinergically and non‐cholinergically mediated contractions of guinea‐pig isolated bronchial muscle , 1990, The Journal of pharmacy and pharmacology.

[15]  J. Lammers,et al.  A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. , 1989, Journal of applied physiology.

[16]  K. Chung,et al.  Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma. , 1989, Thorax.

[17]  T. Ahmed,et al.  Is there loss of protective muscarinic receptor mechanism in asthma? , 1989, Chest.

[18]  N. Thomson,et al.  Lidocaine-induced bronchoconstriction in asthmatic patients. Relation to histamine airway responsiveness and effect of preservative. , 1989, Chest.

[19]  N. Choudry,et al.  Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. , 1989, The American review of respiratory disease.

[20]  Fuller Rw.  Cough associated with angiotensin-converting enzyme inhibitors. , 1989 .

[21]  P. Ind,et al.  Anticholinergic blockade of beta-blocker-induced bronchoconstriction. , 1989, The American review of respiratory disease.

[22]  K. Nikander,et al.  Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler® , 1989, Allergy.

[23]  P. Barnes,et al.  Muscarinic receptor subtypes: implications for lung disease. , 1989, Thorax.

[24]  P. Barnes,et al.  Inhibition of cholinergic neurotransmission in human airways by beta 2-adrenoceptors. , 1988, Journal of applied physiology.

[25]  S. Holgate,et al.  Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution. , 1988, Thorax.

[26]  J. Lammers,et al.  Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo. , 1988, Journal of applied physiology.

[27]  S. Holgate,et al.  Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebuliser solution. , 1987, British medical journal.

[28]  M. Church,et al.  Inhibition of IgE‐dependent histamine release from human dispersed lung mast cells by anti‐allergic drugs and salbutamol , 1987, British journal of pharmacology.

[29]  P. Barnes,et al.  The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. , 1987, British journal of clinical pharmacology.

[30]  D. Allen,et al.  Monosodium L-glutamate-induced asthma. , 1987, The Journal of allergy and clinical immunology.

[31]  P. Barnes.  Neural control of human airways in health and disease. , 2015, The American review of respiratory disease.

[32]  L. Hendeles,et al.  Evaluation of the asthmogenicity of propafenone, a new antiarrhythmic drug. Comparison of spirometry with methacholine challenge. , 1986, Chest.

[33]  R. J. Clark.  EXACERBATION OF ASTHMA AFTER NEBULISED BECLOMETHASONE DIPROPRIONATE , 1986, The Lancet.

[34]  R. Simon,et al.  Adverse reactions to tartrazine. , 1986, The Journal of allergy and clinical immunology.

[35]  P. Barnes.  Endogenous catecholamines and asthma. , 1986, The Journal of allergy and clinical immunology.

[36]  M. Iseman,et al.  The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects. , 1986, The American review of respiratory disease.

[37]  Dildar Ahmad,et al.  Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma , 1986, Clinical pharmacology and therapeutics.

[38]  P. Ind,et al.  Plasma histamine concentration during propranolol induced bronchoconstriction. , 1985, Thorax.

[39]  P. Barnes,et al.  Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. , 1985, The American review of respiratory disease.

[40]  J. Lammers,et al.  Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease. , 1985, British journal of clinical pharmacology.

[41]  Metered dose inhaler induced bronchospasm in asthmatic patients. , 1985, Annals of allergy.

[42]  R. Simon,et al.  Sulfites and asthma. , 1984, The Journal of allergy and clinical immunology.

[43]  H. Schwartz,et al.  Bronchospastic responses to aerosolized metabisulfite in asthmatic subjects: potential mechanisms and clinical implications. , 1984, The Journal of allergy and clinical immunology.

[44]  Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. , 1984, British medical journal.

[45]  U. Ney.  Propranolol‐induced airway hyperreactivity in guinea‐pigs , 1983, British journal of pharmacology.

[46]  C. Herwaarden,et al.  β-adrenoceptor Blockade and Pulmonary Function in Patients Suffering from Chronic Obstructive Lung Disease , 1983 .

[47]  J. Zaagsma,et al.  Comparison of functional beta-adrenoceptor heterogeneity in central and peripheral airway smooth muscle of guinea pig and man. , 1983, Journal of receptor research.

[48]  E. R. Mcfadden,et al.  Controlled-analysis of the effects of inhaled lignocaine in exercise-induced asthma. , 1982, Thorax.

[49]  S. Tarlo,et al.  Tartrazine and benzoate challenge and dietary avoidance in chronic asthma , 1982, Clinical allergy.

[50]  Allen Dh,et al.  Chinese-restaurant asthma. , 1981, The New England journal of medicine.

[51]  K. de Vries,et al.  The role of the adrenergic system in allergy and bronchial hyperreactivity. , 1982, European journal of respiratory diseases. Supplement.

[52]  J. Raaijmakers,et al.  Propranolol-induced bronchoconstriction: a non-specific side-effect of beta-adrenergic blocking therapy. , 1981, European journal of pharmacology.

[53]  R. Simon,et al.  Sensitivity to ingested metabisulfites in asthmatic subjects. , 1981, The Journal of allergy and clinical immunology.

[54]  T. Martin,et al.  Timolol-induced bronchospasm in asthmatic bronchitis. , 1981, JAMA.

[55]  U. Ney,et al.  INVESTIGATION OF THE MECHANISM OF PROPRANOLOL‐INDUCED BRONCHOCONSTRICTION , 1979, British journal of pharmacology.

[56]  C. Kumana,et al.  Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation , 1979, Clinical pharmacology and therapeutics.

[57]  N. Thomson.  The effect of different pharmacological agents on respiratory reflexes in normal and asthmatic subjects. , 1979, Clinical science.

[58]  J. Fish,et al.  Effects of inhaled lidocaine on airway function in asthmatic subjects. , 1979, Respiration; international review of thoracic diseases.

[59]  J. Cruickshank,et al.  A comparison of four beta-adrenoceptor antagonists in patients with asthma. , 1978, British journal of clinical pharmacology.

[60]  J. Cruickshank,et al.  Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. , 1978, British journal of clinical pharmacology.

[61]  A. Patwardhan,et al.  The response to lidocaine in bronchial asthma. , 1977, Chest.

[62]  S. Mcgeady,et al.  The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. , 1976, The Journal of allergy and clinical immunology.

[63]  W. Miller,et al.  Effect of nebulized lidocaine on reactive airways. , 2015, The American review of respiratory disease.

[64]  J. M. Anderson,et al.  " NULL CELLS " IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1975, The Lancet.

[65]  A. Tattersfield,et al.  Effects of beta-adrenergic blockade and stimulation on normal human airways. , 1973, Journal of applied physiology.

[66]  C. G. Ingram,et al.  Effect of propranolol on ventilatory function. , 1966, The American journal of cardiology.

[67]  G. Beall,et al.  Bronchial response to beta-adrenergic blockade. , 1966, The New England journal of medicine.

[68]  R. S. Mcneill.  EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS , 1964 .